Go Pro

Oscar Health, Inc. (NYSE:OSCR) Stock Now Rated "Hold" by Sell-Side Analysts

Oscar Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Oscar Health has a consensus “Hold” rating from 13 analysts: eight holds, three buys, one strong buy and one sell. The average 12-month price target is $33.90, above the reported share price of $29.69.
  • The company reported strong quarterly results, posting $1.10 EPS versus the $0.40 consensus estimate and $4.88 billion in revenue, up 70.4% year over year. Analysts expect full-year EPS of $1.83.
  • Insiders sold 874,451 shares worth approximately $26.8 million over the past three months, while hedge funds and other institutions own 75.7% of the stock.
  • Five stocks to consider instead of Oscar Health.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has received a consensus rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $33.90.

OSCR has been the subject of several analyst reports. Wall Street Zen upgraded Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. UBS Group lifted their price target on Oscar Health from $20.00 to $26.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Weiss Ratings raised shares of Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. Piper Sandler reissued an "overweight" rating and issued a $48.00 price objective on shares of Oscar Health in a report on Thursday, September 17th. Finally, Zacks Research upgraded shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th.

Check Out Our Latest Report on Oscar Health

Insider Buying and Selling at Oscar Health

In related news, insider Adam Mcananey sold 9,092 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $285,943.40. Following the completion of the transaction, the insider directly owned 209,004 shares in the company, valued at approximately $6,573,175.80. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 958 shares of the firm's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $30,129.10. Following the sale, the chief accounting officer directly owned 213,631 shares of the company's stock, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 874,451 shares of company stock worth $26,761,671. Insiders own 22.64% of the company's stock.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds have recently modified their holdings of OSCR. Tidal Investments LLC purchased a new stake in Oscar Health in the 2nd quarter valued at about $2,240,000. Integrated Wealth Concepts LLC purchased a new position in Oscar Health during the second quarter worth about $232,000. IFP Advisors Inc boosted its stake in Oscar Health by 69.5% during the second quarter. IFP Advisors Inc now owns 2,139 shares of the company's stock worth $61,000 after buying an additional 877 shares during the period. Mraz Amerine & Associates Inc. acquired a new stake in shares of Oscar Health during the second quarter valued at about $284,000. Finally, Allworth Financial LP increased its position in shares of Oscar Health by 124.9% during the second quarter. Allworth Financial LP now owns 2,031 shares of the company's stock valued at $58,000 after acquiring an additional 1,128 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Trading Up 0.3%

Shares of Oscar Health stock opened at $29.69 on Tuesday. The stock has a market cap of $9.16 billion, a P/E ratio of 21.21, a P/E/G ratio of 0.32 and a beta of 2.37. The stock's 50 day simple moving average is $30.75 and its 200-day simple moving average is $24.77. Oscar Health has a 1-year low of $10.69 and a 1-year high of $34.48. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion during the quarter, compared to analysts' expectations of $4.73 billion. During the same quarter last year, the firm earned ($0.89) earnings per share. The business's revenue for the quarter was up 70.4% on a year-over-year basis. Analysts predict that Oscar Health will post 1.83 EPS for the current fiscal year.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company's primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.

Recommended Stories

Analyst Recommendations for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines